Procedures | Screen | Scout | Treatment | SPECT/CT | Follow-upa | S | Post-S visitb |
---|---|---|---|---|---|---|---|
Informed consent | E | Â | Â | Â | Â | Â | Â |
In-/exclusion | E | E | Â | Â | Â | Â | Â |
Demographic data | X | Â | Â | Â | Â | Â | Â |
Physical exam, vital signs and clinical performance status (ECOG) | X | E | X | Â | X | X | X |
EORTC QLQ C30, HCC 18, BPI-SF | E | E | E | Â | E | E | E |
MRI / CT liver | X | Â | Â | Â | Xc | Xc | Xc |
CT thorax | X | Â | Â | Â | Â | Â | Â |
HBS | X | Â | Â | Â | X | Â | Â |
Angiography | Â | E | Ed | Â | Â | Â | Â |
Scout dose | Â | E | Â | Â | Â | Â | Â |
Therapeutic dose | Â | Â | E | Â | Â | Â | Â |
SPECT/CT + contrast CT |  | E |  | Ee |  |  |  |
Laboratory examination | X | E | X | Â | X | X | X |
Monitoring of (S)AE’s +  concomitant med |  | E | X |  | X | X | X |
Pregnancy test | Â | X | Â | Â | Â | Â | Â |